REQUEST A DEMO
Total
USD $0.00
Search more companies

Laboratorio Quimico Farmaceutico Industrial Delta S.A (Bolivia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Laboratorio Quimico Farmaceutico Industrial Delta S.A Profile Updated: March 25, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Laboratorio Quimico Farmaceutico Industrial Delta S.A is an enterprise located in Bolivia, with the main office in La Paz. It operates in the Pharmaceutical Preparation Manufacturing sector. It was first established on May 10, 1987. It currently has a total number of 90 (estimated) employees. The latest financial highlights indicate a net sales revenue increase of 10.34% in 2024. Its’ total assets recorded a negative growth of 6.46%. The net profit margin of Laboratorio Quimico Farmaceutico Industrial Delta S.A increased by 10.04% in 2024.

Headquarters
Calle Tal Tal, #2, Zona Sopocachi, Entre Chaco Y Fernando
La Paz; La Paz;

Contact Details: Purchase the Laboratorio Quimico Farmaceutico Industrial Delta S.A report to view the information.

Basic Information
Total Employees:
Purchase the Laboratorio Quimico Farmaceutico Industrial Delta S.A report to view the information.
Financial Auditors:
Purchase the Laboratorio Quimico Farmaceutico Industrial Delta S.A report to view the information.
Incorporation Date:
May 10, 1987
Key Executives
Purchase this report to view the information.
Administrative Manager
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
Chief Credit and Collection
Company Performance
Financial values in the chart are available after Laboratorio Quimico Farmaceutico Industrial Delta S.A report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BOB. Absolute financial data is included in the purchased report.
Net sales revenue
10.34%
Total Operating Revenue
10.34%
Operating Profit
60.9%
EBITDA
60.9%
Net Profit/Loss for the Period
66.2%
Total Assets
-6.46%
Total Equity
-4.71%
Operating Profit Margin
6.95%
Net Profit Margin
10.04%
Return on Equity (ROE)
8.98%
Debt / Equity
-3.39%
Quick Ratio
-0.39%
Cash Ratio
-0.2%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?